The Parkinson’s Foundation‘s largest annual fundraiser — Moving Day, A Walk for Parkinson’s — is marking its 15th anniversary,…
Articles by Andrea Lobo
Serina Therapeutics has entered into definitive agreements for a private placement that could provide up to $30 million to…
Treatment with pirepemat, an oral medication in the pipeline at Irlab Therapeutics AB, may help reduce the risk of…
Biological changes associated with Parkinson’s disease, including newly identified changes in a signaling network linked to neuroinflammation, or brain…
GT-02287, an oral Parkinson’s disease therapy from Gain Therapeutics, showed promising results in a Phase 1b trial. Over three…
Young adults with autism may show abnormalities in the activity of dopamine transporters — proteins that recycle dopamine after its…
GEN Pharmaceuticals has received ethical approval from an accredited medical research ethics committee in the Netherlands to conduct a…
Casma Therapeutics has been awarded $7.6 million from The Michael J. Fox Foundation (MJFF) to support the preclinical…
The integration of Kneu Health’s smartphone-based platform into Cedars-Sinai’s Parkinson’s care program enabled ongoing symptom monitoring and revealed the…
Immunis said it entered into an exclusive deal with Toray for the rights to develop and commercialize a…